November 20, 2024 – IQ-AI Ltd is pleased to announce the appointment of Dr. Al Musella, MD, a prominent figure in the field of brain tumor research and treatment, to its Board of Directors. Dr. Musella brings almost three decades of experience as founder and president of the Musella Foundation for Brain Tumor Research and Information, Inc.
Inspired by his sister-in-law’s battle with glioblastoma (GBM) in 1992, Dr. Musella formed the first online support group for brain tumor patients in 1993, which has since evolved into the compreshensive resource website, virtualtrials.org. Under his leadership, the Musella Foundation has made many significant contributions to the brain tumor community including funding novel research, advocating for the approval of new treatments, and helping patients access needed treatments with financial support.
“We are thrilled to welcome Dr. Musella to our Board of Directors,” said Trevor Brown, Chairman and CEO of IQ-AI. “His extensive network and experience will be invaluable as we forge ahead in the development of oral gallium maltolate and build upon our core imaging business”.
Dr. Musella expressed his enthusiasm about joining the board, stating, “I am honored to join IQ-AI and collaborate with the team at Imaging Biometrics, and I look forward to contributing to their efforts of helping brain tumor patients and the clinicians who support them”.
This appointment follows the resignation of Mr. Vinod Kaushal as a Non-Executive Director effective immediately.
With Dr. Musella, the company strengthens their position to continue and accelerate its trajectory of success and make significant strides in brain tumor management and care.